semaglutide owner Novo Nordisk CEO: could create serious obesity treatment market Novo Nordisk CEO looks beyond

Reference source not found

Women using oral contraceptives should use a non-oral contraceptive method or a backup method for 4 weeks after starting tirzepatide and for 4 weeks after each dose increase due to potential reduced absorption

What GLP-1 medications might change (and why it matters for pills) GLP1 receptor agonists affect the gut in ways that are central to how they work: they can slow gastric emptying and often cause nausea, sometimes vomiting, and sometimes diarrhea

Lin H-T, Tsai Y-F, Liao P-L, Wei JCC

GLP-1s, crucial for managing diabetes and obesity, present unique risks including potential liability issues and regulatory challenges

Fatemeh, T